Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ENERGEN CORPEGN · Entity 12094 | Potential Group Members | June 13, 2018 | June 18, 2018 |
| FORESCOUT TECHNOLOGIES, INCFSCT · Entity 147163 | Potential Group Members | October 18, 2019 | October 28, 2019 |
| GeneDx Holdings Corp.WGS · Entity 1634 | Director · 10% owner | May 13, 2026 | May 15, 2026 |
| Vestis CorpVSTS · Entity 1759 | Director · 10% owner | December 16, 2025 | December 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 7,710,474 |
Reported balance
Holding disclosure · report date 2018-06-13 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,710,474 F1: Shares of common stock (the "Shares") of Energen Corporation (the "Issuer") held for the accounts of certain private investment funds for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP (collectively, the "Corvex Funds"). The general partner of Corvex is controlled by Mr. Meister. F2: For purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of Corvex and Mr. Meister disclaims beneficial ownership of the securities of the Issuer held directly by the Corvex Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Corvex or Mr. Meister is the beneficial owner of such securities for purposes of Section 16 or any other purpose. F3: Corvex and Mr. Meister may be deemed to be members of a "group" for purposes of Section 13(d)(3) of the Exchange Act with High River Limited Partnership, Hopper Investments LLC, Barberry Corp., Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp. and Carl C. Icahn (collectively, the "Icahn Persons"). Subject to Footnote 4 below, none of Corvex, the Corvex Funds or Mr. Meister has any pecuniary interest in any Shares beneficially owned by any of the Icahn Persons and each of Corvex, the Corvex Funds and Mr. Meister disclaims beneficial ownership of such Shares. The Icahn Persons are separately filing a Form 3. |
| Call Options (obligation to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $67.37 · Expires 2018-11-18 | IndirectSee Footnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2018-06-13 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: Shares of common stock (the "Shares") of Energen Corporation (the "Issuer") held for the accounts of certain private investment funds for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP (collectively, the "Corvex Funds"). The general partner of Corvex is controlled by Mr. Meister. F2: For purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of Corvex and Mr. Meister disclaims beneficial ownership of the securities of the Issuer held directly by the Corvex Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Corvex or Mr. Meister is the beneficial owner of such securities for purposes of Section 16 or any other purpose. F3: Corvex and Mr. Meister may be deemed to be members of a "group" for purposes of Section 13(d)(3) of the Exchange Act with High River Limited Partnership, Hopper Investments LLC, Barberry Corp., Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp. and Carl C. Icahn (collectively, the "Icahn Persons"). Subject to Footnote 4 below, none of Corvex, the Corvex Funds or Mr. Meister has any pecuniary interest in any Shares beneficially owned by any of the Icahn Persons and each of Corvex, the Corvex Funds and Mr. Meister disclaims beneficial ownership of such Shares. The Icahn Persons are separately filing a Form 3. F4: On May 20, 2018, Corvex and the Corvex Funds (the "Corvex Parties") and High River Limited Partnership, Icahn Partners LP and Icahn Partners Master Fund LP (the "Icahn Group") entered into a Stock Option Agreement (the "Option Agreement") pursuant to which the Corvex Parties granted the Icahn Group an option (the "Option") to purchase 2,000,000 Shares in the aggregate at a price of $67.37 per Share. Prior to exercise of the Option, the Corvex Parties shall retain all incidents of ownership of the underlying Shares, including, without limitation, all voting rights, and the Icahn Group shall not have the right, and shall not, direct the voting of any Shares prior to the exercise of the Option. F5: (Continued from footnote 4) The Corvex Parties shall hold for the benefit of the Icahn Group and deliver to the Icahn Group upon the exercise of the Option, any and all dividends or other distributions with respect to the Shares (whether payable in cash, securities or other assets) that are issued, paid, or as to which a record date is set while the Corvex Parties are holders of record, on or following the date of the Option Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of common stock (the "Shares") of Energen Corporation (the "Issuer") held for the accounts of certain private investment funds for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP (collectively, the "Corvex Funds"). The general partner of Corvex is controlled by Mr. Meister.
F2: For purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of Corvex and Mr. Meister disclaims beneficial ownership of the securities of the Issuer held directly by the Corvex Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Corvex or Mr. Meister is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
F3: Corvex and Mr. Meister may be deemed to be members of a "group" for purposes of Section 13(d)(3) of the Exchange Act with High River Limited Partnership, Hopper Investments LLC, Barberry Corp., Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp. and Carl C. Icahn (collectively, the "Icahn Persons"). Subject to Footnote 4 below, none of Corvex, the Corvex Funds or Mr. Meister has any pecuniary interest in any Shares beneficially owned by any of the Icahn Persons and each of Corvex, the Corvex Funds and Mr. Meister disclaims beneficial ownership of such Shares. The Icahn Persons are separately filing a Form 3.
F4: On May 20, 2018, Corvex and the Corvex Funds (the "Corvex Parties") and High River Limited Partnership, Icahn Partners LP and Icahn Partners Master Fund LP (the "Icahn Group") entered into a Stock Option Agreement (the "Option Agreement") pursuant to which the Corvex Parties granted the Icahn Group an option (the "Option") to purchase 2,000,000 Shares in the aggregate at a price of $67.37 per Share. Prior to exercise of the Option, the Corvex Parties shall retain all incidents of ownership of the underlying Shares, including, without limitation, all voting rights, and the Icahn Group shall not have the right, and shall not, direct the voting of any Shares prior to the exercise of the Option.
F5: (Continued from footnote 4) The Corvex Parties shall hold for the benefit of the Icahn Group and deliver to the Icahn Group upon the exercise of the Option, any and all dividends or other distributions with respect to the Shares (whether payable in cash, securities or other assets) that are issued, paid, or as to which a record date is set while the Corvex Parties are holders of record, on or following the date of the Option Agreement.
FORESCOUT TECHNOLOGIES, INC
Report date October 18, 2019 · Filed October 28, 2019
Jointly reported with Meister Keith A.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 3,344,133 |
Reported balance
Holding disclosure · report date 2019-10-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,344,133 F1: Shares of common stock (the "Shares") of Forescout Technologies, Inc. (the "Issuer") held for the accounts of certain private investment funds for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP (collectively, the "Corvex Funds"). The general partner of Corvex is controlled by Keith Meister. F2: For purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of Corvex and Mr. Meister disclaims beneficial ownership of the securities of the Issuer held directly by the Corvex Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Corvex or Mr. Meister is the beneficial owner of such securities for purposes of Section 16 or any other purpose. F3: Corvex and Mr. Meister may be deemed to be members of a "group" for purposes of Section 13(d)(3) of the Exchange Act with Jericho Capital Asset Management L.P. and certain of its affiliates (the "Jericho Persons"). None of Corvex, the Corvex Funds or Mr. Meister has any pecuniary interest in any Shares beneficially owned by any of the Jericho Persons and each of Corvex, the Corvex Funds and Mr. Meister disclaims beneficial ownership of such Shares. The Jericho Persons are separately filing a Form 3. The filing of this Form 3 is being made as the collective beneficial ownership of Shares held by Corvex and Mr. Meister and the Jericho Persons (based upon the information contained in the Schedule 13D filed by the Jericho Persons) exceeds 10 percent of the outstanding Shares, and the filing of this Form 3 shall not be considered an admission that Corvex and Mr. Meister are members of a "group" with the Jericho Persons. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of common stock (the "Shares") of Forescout Technologies, Inc. (the "Issuer") held for the accounts of certain private investment funds for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP (collectively, the "Corvex Funds"). The general partner of Corvex is controlled by Keith Meister.
F2: For purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of Corvex and Mr. Meister disclaims beneficial ownership of the securities of the Issuer held directly by the Corvex Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Corvex or Mr. Meister is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
F3: Corvex and Mr. Meister may be deemed to be members of a "group" for purposes of Section 13(d)(3) of the Exchange Act with Jericho Capital Asset Management L.P. and certain of its affiliates (the "Jericho Persons"). None of Corvex, the Corvex Funds or Mr. Meister has any pecuniary interest in any Shares beneficially owned by any of the Jericho Persons and each of Corvex, the Corvex Funds and Mr. Meister disclaims beneficial ownership of such Shares. The Jericho Persons are separately filing a Form 3. The filing of this Form 3 is being made as the collective beneficial ownership of Shares held by Corvex and Mr. Meister and the Jericho Persons (based upon the information contained in the Schedule 13D filed by the Jericho Persons) exceeds 10 percent of the outstanding Shares, and the filing of this Form 3 shall not be considered an admission that Corvex and Mr. Meister are members of a "group" with the Jericho Persons.
GeneDx Holdings Corp.
Report date May 13, 2026 · Filed May 15, 2026
Jointly reported with Meister Keith A.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 4,784,570 |
Last balance in matching sequence
After 2026-05-15 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rowsRow 1 · 2026-05-13 · Purchase · Acquired 94,074 · Balance 4,527,371 F1: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.21 to $39.20. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7) and (8) to this Form 4. F2: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Row 2 · 2026-05-13 · Purchase · Acquired 70,926 · Balance 4,598,297 F4: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.21 to $39.80. F2: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Row 3 · 2026-05-14 · Purchase · Acquired 88,107 · Balance 4,686,404 F5: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.79 to $39.77. F2: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Row 4 · 2026-05-14 · Purchase · Acquired 51,893 · Balance 4,738,297 F6: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.79 to $40.00. F2: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Row 5 · 2026-05-15 · Purchase · Acquired 27,408 · Balance 4,765,705 F7: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.78 to $38.77. F2: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Row 6 · 2026-05-15 · Purchase · Acquired 18,865 · Balance 4,784,570 F8: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.78 to $40.60. F2: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 333,144 |
Reported balance
Holding disclosure · report date 2026-05-13 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 333,144 F9: CMLS Holdings LLC ("CMLS Holdings") is the record holder of 333,144 shares of the Class A Common Stock reported herein. Mr. Meister is one of two members of the Board of Managers of CMLS Holdings, and Mr. Meister shares voting and investment discretion with respect to the securities held of record by CMLS Holdings reported herein. |
| Class A Common StockSEC Table I · non-derivative | Direct | 20,129 |
Reported balance
Holding disclosure · report date 2026-05-13 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 20,129 F10: The shares of Class A Common Stock reflected as beneficially owned by Mr. Meister include 20,129 shares of Class A Common Stock that were issued upon the vesting of restricted stock units, that were granted to Mr. Meister in connection with his service on the board of directors of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.21 to $39.20. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7) and (8) to this Form 4.
F2: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex.
F3: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.
F4: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.21 to $39.80.
F5: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.79 to $39.77.
F6: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.79 to $40.00.
F7: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.78 to $38.77.
F8: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.78 to $40.60.
F9: CMLS Holdings LLC ("CMLS Holdings") is the record holder of 333,144 shares of the Class A Common Stock reported herein. Mr. Meister is one of two members of the Board of Managers of CMLS Holdings, and Mr. Meister shares voting and investment discretion with respect to the securities held of record by CMLS Holdings reported herein.
F10: The shares of Class A Common Stock reflected as beneficially owned by Mr. Meister include 20,129 shares of Class A Common Stock that were issued upon the vesting of restricted stock units, that were granted to Mr. Meister in connection with his service on the board of directors of the Issuer.
Vestis Corp
Report date December 16, 2025 · Filed December 17, 2025
Jointly reported with Meister Keith A.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 19,813,963 |
Last balance in matching sequence
After 2025-12-17 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-12-16 · Purchase · Acquired 800,222 · Balance 19,604,121 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.67 to $7.00, inclusive. The reporting persons undertake to provide to Vestis Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (4) to this Form 4. F2: Investment funds advised by Corvex Management LP ("Corvex") directly hold 19,813,963 shares of common stock of the Issuer reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Row 2 · 2025-12-17 · Purchase · Acquired 209,842 · Balance 19,813,963 F4: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.70 to $6.80, inclusive. F2: Investment funds advised by Corvex Management LP ("Corvex") directly hold 19,813,963 shares of common stock of the Issuer reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. |
| Common StockSEC Table I · non-derivative | Direct | 16,231.994 |
Reported balance
Holding disclosure · report date 2025-12-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 16,231.994 F5: Represents shares of common stock received upon the vesting of restricted stock units and additional restricted stock units granted to Mr. Meister in respect of his service on the Board of Directors of the Issuer and additional restricted stock units accrued in connection with the Issuer's quarterly dividend on previously awarded restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.67 to $7.00, inclusive. The reporting persons undertake to provide to Vestis Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (4) to this Form 4.
F2: Investment funds advised by Corvex Management LP ("Corvex") directly hold 19,813,963 shares of common stock of the Issuer reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex.
F3: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.
F4: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.70 to $6.80, inclusive.
F5: Represents shares of common stock received upon the vesting of restricted stock units and additional restricted stock units granted to Mr. Meister in respect of his service on the Board of Directors of the Issuer and additional restricted stock units accrued in connection with the Issuer's quarterly dividend on previously awarded restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 15, 2026 23:07 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 18,865 | $39.83 | $751,392.95 |
DisclosureSEC source: 0001011438-26-000351 · form4.xml · nonDerivative · entry 6 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,784,570 F8 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.78 to $40.60. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 15, 2026 Filed May 15, 2026 23:07 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 27,408 | $38.28 | $1,049,178.24 |
DisclosureSEC source: 0001011438-26-000351 · form4.xml · nonDerivative · entry 5 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,765,705 F7 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.78 to $38.77. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 14, 2026 Filed May 15, 2026 23:07 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 51,893 | $39.92 | $2,071,568.56 |
DisclosureSEC source: 0001011438-26-000351 · form4.xml · nonDerivative · entry 4 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,738,297 F6 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.79 to $40.00. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 14, 2026 Filed May 15, 2026 23:07 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 88,107 | $39.08 | $3,443,221.56 |
DisclosureSEC source: 0001011438-26-000351 · form4.xml · nonDerivative · entry 3 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,686,404 F5 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.79 to $39.77. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 13, 2026 Filed May 15, 2026 23:07 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 70,926 | $39.45 | $2,798,030.70 |
DisclosureSEC source: 0001011438-26-000351 · form4.xml · nonDerivative · entry 2 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,598,297 F4 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.21 to $39.80. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 13, 2026 Filed May 15, 2026 23:07 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 94,074 | $38.82 | $3,651,952.68 |
DisclosureSEC source: 0001011438-26-000351 · form4.xml · nonDerivative · entry 1 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,527,371 F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.21 to $39.20. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7) and (8) to this Form 4. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 532 | $40.35 | $21,466.20 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 13 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,433,297 F15 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.22 to $40.41. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 252,734 | $39.65 | $10,020,903.10 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 12 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,432,765 F14 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.22 to $40.21. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 246,734 | $38.91 | $9,600,419.94 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 11 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,180,031 F13 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.22 to $39.21. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 08, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 73,104 | $41.15 | $3,008,229.60 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 10 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,933,297 F12 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.95 to $41.50. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 08, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 79,144 | $40.67 | $3,218,786.48 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 9 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,860,193 F11 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.95 to $40.94. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 08, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 3,396 | $38.70 | $131,425.20 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 8 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,781,049 F10 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.59 to $38.94. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 08, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 15,745 | $38.00 | $598,310.00 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 7 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,777,653 F9 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.59 to $38.58. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 56,630 | $40.46 | $2,291,249.80 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 6 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,761,908 F8 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.05 to $40.66. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 94,356 | $39.39 | $3,716,682.84 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 5 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,705,278 F7 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.05 to $40.04. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 116,412 | $38.46 | $4,477,205.52 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 4 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,610,922 F6 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.05 to $39.04. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 123,393 | $37.60 | $4,639,576.80 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 3 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,494,510 F5 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.05 to $38.04. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 14,786 | $36.33 | $537,175.38 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 2 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,371,117 F4 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $35.97 to $36.84. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:21 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 128,181 | $35.46 | $4,545,298.26 |
DisclosureSEC source: 0001011438-26-000276 · form4.xml · nonDerivative · entry 1 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,356,331 F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $34.97 to $35.94. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14) and (15) to this Form 4. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 00:19 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 29,236 | $82.06 | $2,399,106.16 |
DisclosureSEC source: 0001193125-26-094527 · ownership.xml · nonDerivative · entry 10 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,228,150 F11 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $81.95 to $82.37. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 3,228,150 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 00:19 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 60,892 | $81.37 | $4,954,782.04 |
DisclosureSEC source: 0001193125-26-094527 · ownership.xml · nonDerivative · entry 9 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,198,914 F10 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $80.95 to $81.94. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 3,228,150 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 00:19 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 47,623 | $80.55 | $3,836,032.65 |
DisclosureSEC source: 0001193125-26-094527 · ownership.xml · nonDerivative · entry 8 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,138,022 F9 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $79.95 to $80.94. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 3,228,150 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 00:19 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 1,971 | $78.91 | $155,531.61 |
DisclosureSEC source: 0001193125-26-094527 · ownership.xml · nonDerivative · entry 7 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,090,399 F8 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $78.75 to $79.00. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 3,228,150 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 00:19 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 304 | $77.96 | $23,699.84 |
DisclosureSEC source: 0001193125-26-094527 · ownership.xml · nonDerivative · entry 6 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,088,428 F7 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $77.50 to $78.37. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 3,228,150 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:19 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 249 | $75.99 | $18,921.51 |
DisclosureSEC source: 0001193125-26-094527 · ownership.xml · nonDerivative · entry 5 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,088,124 F6 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $75.97 to $76.00. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 3,228,150 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:19 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 921 | $75.66 | $69,682.86 |
DisclosureSEC source: 0001193125-26-094527 · ownership.xml · nonDerivative · entry 4 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,087,875 F5 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $74.97 to $75.96. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 3,228,150 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:19 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 200 | $72.00 | $14,400.00 |
DisclosureSEC source: 0001193125-26-094527 · ownership.xml · nonDerivative · entry 3 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,086,954 F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 3,228,150 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:19 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 8,439 | $71.48 | $603,219.72 |
DisclosureSEC source: 0001193125-26-094527 · ownership.xml · nonDerivative · entry 2 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,086,754 F4 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $71.00 to $71.97. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 3,228,150 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:19 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 19,686 | $70.34 | $1,384,713.24 |
DisclosureSEC source: 0001193125-26-094527 · ownership.xml · nonDerivative · entry 1 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,078,315 F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $69.99 to $70.78. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7), (8), (9), (10), and (11) to this Form 4. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 3,228,150 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 23:20 UTC | Vestis Corp VSTS · Entity 1759 | PurchaseCommon Stock | 209,842 | $6.79 | $1,424,827.18 |
DisclosureSEC source: 0001193125-25-323149 · ownership.xml · nonDerivative · entry 2 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 19,813,963 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.70 to $6.80, inclusive. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") directly hold 19,813,963 shares of common stock of the Issuer reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 23:20 UTC | Vestis Corp VSTS · Entity 1759 | PurchaseCommon Stock | 800,222 | $6.81 | $5,449,511.82 |
DisclosureSEC source: 0001193125-25-323149 · ownership.xml · nonDerivative · entry 1 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 19,604,121 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.67 to $7.00, inclusive. The reporting persons undertake to provide to Vestis Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (4) to this Form 4. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") directly hold 19,813,963 shares of common stock of the Issuer reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 28, 2025 Filed May 28, 2025 22:45 UTC | Vestis Corp VSTS · Entity 1759 | PurchaseCommon Stock | 314,390 | $6.03 | $1,895,771.70 |
DisclosureSEC source: 0000950170-25-078495 · ownership.xml · nonDerivative · entry 3 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 18,803,899 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.99 to $6.12, inclusive. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") directly hold 18,489,509 shares of common stock of the Issuer reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 27, 2025 Filed May 28, 2025 22:45 UTC | Vestis Corp VSTS · Entity 1759 | PurchaseCommon Stock | 109,008 | $6.05 | $659,498.40 |
DisclosureSEC source: 0000950170-25-078495 · ownership.xml · nonDerivative · entry 2 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 18,489,509 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.96 to $6.11, inclusive. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") directly hold 18,489,509 shares of common stock of the Issuer reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 23, 2025 Filed May 28, 2025 22:45 UTC | Vestis Corp VSTS · Entity 1759 | PurchaseCommon Stock | 377,277 | $5.89 | $2,222,161.53 |
DisclosureSEC source: 0000950170-25-078495 · ownership.xml · nonDerivative · entry 1 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 18,380,501 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.70 to $6.00, inclusive. The reporting persons undertake to provide to Vestis Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (4), and (5) to this Form 4. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") directly hold 18,489,509 shares of common stock of the Issuer reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:00 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 24,644 | $60.52 | $1,491,454.88 |
DisclosureSEC source: 0000950170-25-073497 · ownership.xml · nonDerivative · entry 2 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,058,629 F4 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $60.17 to $61.00. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the direct holders of 3,058,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:00 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 25,356 | $59.81 | $1,516,542.36 |
DisclosureSEC source: 0000950170-25-073497 · ownership.xml · nonDerivative · entry 1 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,033,985 F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $59.16 to $60.15. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnotes (1) and (4) to this Form 4. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the direct holders of 3,058,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 09, 2025 Filed May 12, 2025 23:50 UTC | Vestis Corp VSTS · Entity 1759 | PurchaseCommon Stock | 138,048 | $6.32 | $872,463.36 |
DisclosureSEC source: 0000950170-25-069598 · ownership.xml · nonDerivative · entry 2 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 18,003,224 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.13 to $6.46, inclusive. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") directly hold 18,003,224 shares of common stock of the Issuer reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 08, 2025 Filed May 12, 2025 23:50 UTC | Vestis Corp VSTS · Entity 1759 | PurchaseCommon Stock | 857,299 | $6.11 | $5,238,096.89 |
DisclosureSEC source: 0000950170-25-069598 · ownership.xml · nonDerivative · entry 1 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 17,865,176 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.81 to $6.33, inclusive. The reporting persons undertake to provide to Vestis Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (4) to this Form 4. F2 · ownership.nature: Investment funds advised by Corvex Management LP ("Corvex") directly hold 18,003,224 shares of common stock of the Issuer reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 08, 2025 Filed May 12, 2025 23:46 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 9,867 | $57.53 | $567,648.51 |
DisclosureSEC source: 0000950170-25-069593 · ownership.xml · nonDerivative · entry 3 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,008,629 F5 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $57.28 to $57.86. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the direct holders of 3,008,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 08, 2025 Filed May 12, 2025 23:46 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 10,897 | $56.96 | $620,693.12 |
DisclosureSEC source: 0000950170-25-069593 · ownership.xml · nonDerivative · entry 2 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,998,762 F4 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $56.27 to $57.26. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the direct holders of 3,008,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 08, 2025 Filed May 12, 2025 23:46 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 79,236 | $55.69 | $4,412,652.84 |
DisclosureSEC source: 0000950170-25-069593 · ownership.xml · nonDerivative · entry 1 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,987,865 F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $55.27 to $56.22. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnotes (1), (4), and (5) to this Form 4. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the direct holders of 3,008,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F3 · ownership.nature: For the purposes of this filing, each of Corvex or Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 06, 2025 Filed May 7, 2025 01:45 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | GrantClass A Common Stock | 9,728 | $63.96 | $622,202.88 |
DisclosureSEC source: 0000950170-25-064863 · ownership.xml · nonDerivative · entry 12 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,908,629 F15 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $63.67 to $64.25. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the record holders of 2,908,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F4 · ownership.nature: For the purposes of this filing, Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 06, 2025 Filed May 7, 2025 01:45 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | GrantClass A Common Stock | 42,500 | $63.08 | $2,680,900.00 |
DisclosureSEC source: 0000950170-25-064863 · ownership.xml · nonDerivative · entry 11 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,898,901 F14 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $62.66 to $63.65. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the record holders of 2,908,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F4 · ownership.nature: For the purposes of this filing, Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 06, 2025 Filed May 7, 2025 01:45 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | GrantClass A Common Stock | 44,942 | $62.19 | $2,794,942.98 |
DisclosureSEC source: 0000950170-25-064863 · ownership.xml · nonDerivative · entry 10 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,856,401 F13 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $61.66 to $62.65. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the record holders of 2,908,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F4 · ownership.nature: For the purposes of this filing, Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 06, 2025 Filed May 7, 2025 01:45 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | GrantClass A Common Stock | 26,798 | $61.20 | $1,640,037.60 |
DisclosureSEC source: 0000950170-25-064863 · ownership.xml · nonDerivative · entry 9 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,811,459 F12 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $60.60 to $61.53. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the record holders of 2,908,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F4 · ownership.nature: For the purposes of this filing, Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 05, 2025 Filed May 7, 2025 01:45 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | GrantClass A Common Stock | 7,528 | $66.97 | $504,150.16 |
DisclosureSEC source: 0000950170-25-064863 · ownership.xml · nonDerivative · entry 8 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,784,661 F11 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $66.82 to $67.37. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the record holders of 2,908,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F4 · ownership.nature: For the purposes of this filing, Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 05, 2025 Filed May 7, 2025 01:45 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | GrantClass A Common Stock | 42,472 | $65.96 | $2,801,453.12 |
DisclosureSEC source: 0000950170-25-064863 · ownership.xml · nonDerivative · entry 7 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,777,133 F10 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $65.82 to $66.81. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the record holders of 2,908,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F4 · ownership.nature: For the purposes of this filing, Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 05, 2025 Filed May 7, 2025 01:45 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | GrantClass A Common Stock | 62,198 | $65.34 | $4,064,017.32 |
DisclosureSEC source: 0000950170-25-064863 · ownership.xml · nonDerivative · entry 6 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,734,661 F9 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $64.79 to $65.75. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the record holders of 2,908,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F4 · ownership.nature: For the purposes of this filing, Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 05, 2025 Filed May 7, 2025 01:45 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | GrantClass A Common Stock | 40,335 | $64.45 | $2,599,590.75 |
DisclosureSEC source: 0000950170-25-064863 · ownership.xml · nonDerivative · entry 5 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,672,463 F8 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $63.79 to $64.78. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the record holders of 2,908,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F4 · ownership.nature: For the purposes of this filing, Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
| May 02, 2025 Filed May 7, 2025 01:45 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | GrantClass A Common Stock | 51,172 | $64.95 | $3,323,621.40 |
DisclosureSEC source: 0000950170-25-064863 · ownership.xml · nonDerivative · entry 4 Meister Keith A. · CIK 0001307631 · Director · 10% owner Corvex Management LP · CIK 0001535472 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,632,128 F7 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $64.85 to $65.01. F2 · ownership.nature: Investment funds advised by Corvex Management LP are the record holders of 2,908,629 shares of the Class A common stock, par value $0.0001 per share ("Class A Common Stock") of GeneDx Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex Management LP. F4 · ownership.nature: For the purposes of this filing, Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.